EI
CLCD

EAM Investors’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

EAM Investors’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-153,586
Closed -$5.59M – 421
2016
Q4 		$5.59M Sell
153,586
-86,921
-36% -$3.08M 0.74% 7
2016
Q3 		$9.18M Buy
+240,507
New +$3.56M 1.23% 1

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

EAM Investors's CLCD Position: Q1 2017 in Review

EAM Investors sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 153,586 shares — an estimated $5.59M sold.

EAM Investors first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $9.18M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • EAM Investors reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • EAM Investors sold 153,586 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $5.59M.
  • EAM Investors first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • EAM Investors's CoLucid Pharmaceuticals, Inc. position peaked at $9.18M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on EAM Investors's 13F filing for Q1 2017, filed 10 May 2017.